Inhibition of RNA polymerase II as a trigger for the p53 response
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Induction of p53 following ionizing radiation is de®cient in AT and NBS cells while induction of p53 following UV light or MMS treatment is not (Canman et al., 1994; Jongmans et al., 1997; Kastan et al., 1992; Khanna and Lavin, 1993; Lu and Lane, 1993).”
Backgroundp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Hidaka, H., Inagaki, M., Kawamoto, S., & Sasaki, Y. (1984) · Biochemistry · doi:10.1021/bi00316a032 · Cited by 2,687
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Ward, J. F. (1988) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60611-x · Cited by 1,492
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893
Nelson, W. G., & Kastan, M. B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1815 · Cited by 857
Wada, T., Takagi, T., Yamaguchi, Y., Ferdous, A., Imai, T., Hirose, S., Sugimoto, S., Yano, K., Hartzog, G. A., Winston, F., et al. (1998) · Genes & Development · doi:10.1101/gad.12.3.343 · Cited by 750
DNA Topoisomerases: Essential Enzymes and Lethal Targets
Chen, A. Y., & Liu, L. F. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001203 · Cited by 737
Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., & Stark, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.1 · Cited by 726
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645
Graeber, T. G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J., & Giaccia, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6264 · Cited by 614
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579 · cited 1×
“The active form of the p53 protein binds DNA as a tetramer in a sequencedependent manner and transactivates target genes (Farmer et al., 1992; Zambetti et al., 1992) while concurrently reducing transcription of other genes (Ginsberg et al., 1991).”
BackgroundActinomycin and DNA transcription.
Sobell, H. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5328 · Cited by 561
Inhibition of RNA synthesis by actinomycin D: Characteristic dose‐response of different RNA species
Perry, R. P., & Kelley, D. E. (1970) · Journal of Cellular Physiology · doi:10.1002/jcp.1040760202 · Cited by 551
Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A., & Wahl, G. M. (1996) · Genes & Development · doi:10.1101/gad.10.8.934 · Cited by 538
Activation of the cell death program by inhibition of proteasome function
Drexler, H. C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.855 · Cited by 481
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA
Eastman, A. (1986) · Biochemistry · doi:10.1021/bi00361a026 · Cited by 458
Induction of cellular p53 activity by DNA-damaging agents and growth arrest.
Zhan, Q., Carrier, F., & Fornace, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4242 · Cited by 441
Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., & Ross, R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80055-6 · Cited by 441
Wild-type p53 can down-modulate the activity of various promoters.
Ginsberg, D., Mechta, F., Yaniv, M., & Oren, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9979 · Cited by 435
Small peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434
Donahue, B. A., Yin, S., Taylor, J. S., Reines, D., & Hanawalt, P. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8502 · Cited by 357
Jarvis, W. D., Turner, A., Povirk, L. F., et al. (1994) · PubMed · Cited by 354
Ford, J. M., & Hanawalt, P. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8876 · Cited by 346
Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C., & Levine, A. J. (1992) · Genes & Development · doi:10.1101/gad.6.7.1143 · Cited by 311
Ubiquitination of p53 and p21 Is Differentially Affected by Ionizing and UV Radiation
Maki, C. G., & Howley, P. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.355 · Cited by 308
Proteolytic Cleavage of Human p53 by Calpain: a Potential Regulator of Protein Stability
Kubbutat, M. H. G., & Vousden, K. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.460 · Cited by 307
Zandomeni, R., Zandomeni, M. C., Shugar, D., & Weinmann, R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35799-x · Cited by 291
Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage
Cox, L. S., & Lane, D. P. (1995) · BioEssays · doi:10.1002/bies.950170606 · Cited by 287
Harris, C. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1187 · Cited by 285
Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.
Chowdary, D. R., Dermody, J. J., Jha, K. K., & Ozer, H. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1997 · Cited by 278
The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.
Canman, C. E., Wolff, A. C., Chen, C.-Y., Fornace, A. J., & Kastan, M. B. (1994) · PubMed · Cited by 272
In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin
Nguyen, V. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.15.2924 · Cited by 265
Apoptosis induction resulting from proteasome inhibition
SHINOHARA, K., TOMIOKA, M., NAKANO, H., TONÉ, S., ITO, H., & KAWASHIMA, S. (1996) · Biochemical Journal · doi:10.1042/bj3170385 · Cited by 244
Chodosh, L. A., Fire, A., Samuels, M., & Sharp, P. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94169-4 · Cited by 234
Erixon, K., & Ahnström, G. (1979) · Mutation Research · doi:10.1016/0027-5107(79)90164-7 · Cited by 205
Eller, M. S., Maeda, T., Magnoni, C., Atwal, D., & Gilchrest, B. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12627 · Cited by 203
Sehgal, P. B., Darnell Jr., J. E., & Tamm, I. (1976) · Cell · doi:10.1016/0092-8674(76)90092-1 · Cited by 200
Tishler, R. B., Calderwood, S. K., Coleman, C. N., & Price, B. D. (1993) · PubMed · Cited by 200
Yankulov, K., Yamashita, K., Roy, R., Egly, J.-M., & Bentley, D. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23922 · Cited by 191
Taxol induction of p21WAF1 and p53 requires c-raf-1.
Blagosklonny, M. V., Schulte, T. W., Nguyen, P., Mimnaugh, E. G., Trepel, J. B., & Neckers, L. M. (1995) · PubMed · Cited by 182
Selby, C. P., & Sancar, A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45364-6 · Cited by 171
Proteolysis by Calpains: a Possible Contribution to Degradation of p53
Pariat, M., Carillo, S., Molinari, M., Salvat, C., Debüssche, L., Bracco, L., Milner, J., & Piechaczyk, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2806 · Cited by 165
GENE AND TRANSCRIPTION UNIT MAPPING BY RADIATION EFFECTS
Sauerbier, W., & Hercules, K. (1978) · Annual Review of Genetics · doi:10.1146/annurev.ge.12.120178.001553 · Cited by 165
Lu, H., Taya, Y., Ikeda, M., & Levine, A. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6399 · Cited by 162
Translational regulation of human p53 gene expression.
Fu, L., Minden, M. D., & Benchimol, S. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00812.x · Cited by 138
Antioxidant action via p53-mediated apoptosis.
Liu, M., Pelling, J. C., Ju, J., Chu, E., & Brash, D. E. (1998) · PubMed · Cited by 127
Tishler, R. B., Lamppu, D., Park, S., & Price, B. D. (1995) · PubMed · Cited by 123
Dubois, M., Nguyen, V. T., Bellier, S., & Bensaude, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36837-0 · Cited by 122
Jongmans, W., Vuillaume, M., Chrzańowska, K., Smeets, D., Sperling, K., & Hall, J. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5016 · Cited by 117
Mello, J. A., Lippard, S. J., & Essigmann, J. M. (1995) · Biochemistry · doi:10.1021/bi00045a020 · Cited by 101
Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation
ZHAN, Q., FAN, S., SMITH, M. L., BAE, I., YU, K., ALAMO, I., O'CONNOR, P. M., & FORNACE, A. J. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.805 · Cited by 97
How Phosphorylation Regulates the Activity of p53
Steegenga, W. T., van der Eb, A. J., & Jochemsen, A. G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0560 · Cited by 96
McKay, B. C., Ljungman, M. E., & Rainbow, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1201963 · Cited by 92
Self-citationKoumenis, C., & Giaccia, A. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7306 · Cited by 86
Matsumoto, H., Shimura, M., Omatsu, T., Okaichi, K., Majima, H. J., & Ohnishi, T. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90407-3 · Cited by 86
McKay, B. C., Francis, M. A., & Rainbow, A. J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.2.245 · Cited by 79
Self-citationLoignon, M., Fetni, R., Gordon, A. J., & Drobetsky, E. A. (1997) · PubMed · Cited by 75
Corda, Y., Job, C., Anin, M. F., Leng, M., & Job, D. (1993) · Biochemistry · doi:10.1021/bi00084a027 · Cited by 71
Dumaz, N., Duthu, A., Ehrhart, J., Drougard, C., Appella, E., Anderson, C. W., May, P., Sarasin, A. R., & Daya–Grosjean, L. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199712)20:4<340::aid-mc3>3.0.co;2-n · Cited by 66
Ljungman, M. E., & Hanawalt, P. C. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1782 · Cited by 65
Self-citationTranscription Abnormalities Potentiate Apoptosis of Normal Human Fibroblasts
Anděra, L., & Wasylyk, B. (1997) · Molecular Medicine · doi:10.1007/bf03401721 · Cited by 62
p53-dependent induction of WAF1 by cold shock in human glioblastoma cells
Ohnishi, T., Wang, X., Ohnishi, K., & Takahashi, A. (1998) · Oncogene · doi:10.1038/sj.onc.1201663 · Cited by 61
Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells
Poon, R. Y. C., & Hunter, T. (1998) · Oncogene · doi:10.1038/sj.onc.1201897 · Cited by 54
Karlsson, N. G., Johansson, M., Asker, N., Karlsson, H., Gendler, S. J., Carlstedt, I., & Hansson, G. C. (1996) · Glycoconjugate Journal · doi:10.1007/bf00702346 · Cited by 52
Initiation inhibition and reinitiation of the synthesis of heterogeneous nuclear RNA in living cells
Egyházi, E. (1976) · Nature · doi:10.1038/262319a0 · Cited by 43
Signalling to p53: where does it all start?
Kastan, M. B. (1996) · BioEssays · doi:10.1002/bies.950180804 · Cited by 32
Cited by
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,079
Awakening guardian angels: drugging the p53 pathway
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881
Rubbi, C. P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg579 · Cited by 811
Inhibition of transcription by platinum antitumor compounds
Todd, R. C., & Lippard, S. J. (2009) · Metallomics · doi:10.1039/b907567d · Cited by 539
Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms
O’Brien, T. J., Ceryak, S., & Patierno, S. R. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.09.006 · Cited by 509
Metadata
- Authors
- Ljungman, M., Zhang, F., Chen, F., Rainbow, A. J., & McKay, B. C.
- Venue
- Oncogene
- Published
- 1999-01-21
- Volume
- 18
- Issue
- 3
- Pages
- 583-592
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2103625519
- Cited by
- 288
- References
- 75
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.